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The aim of this paper was to evaluate the long-term survival of young stroke patients in Estonia, analyse time trends of survival,
and compare the results with other studies. We have used 2 population-based ﬁrst-ever stroke registry data (1991–1993 and 2001–
2003)toanalysethe1-,5-,and7-yearoutcomeofyoungstrokepatientsbytheKaplan-Meiermethodofanalysis.Fromthegroupof
1206 patients, 129 (11%) were aged under 55 years. The overall survival rate at 1, 5, and 7 years was 0.70 (95% CI 0.62–0.78), 0.63
(95% CI 0.55–0.72), and 0.61 (95% CI 0.53–0.70), respectively. The survival was signiﬁcantly worse for patients with intracerebral
haemorrhage (P<0.01) and for those aged from 45 to 54 years compared to the younger age group from 0 to 44 years (P = 0.03).
For patients with ischemic stroke, aged from 15 to 44 years, the 1-, 5-, and 7-year survival rate was 0.89 (95% CI 0.79–1.00), 0.75
(95%CI0.61–0.93),and0.75(0.61–0.93),respectively.Therewasnodiﬀerenceinoverallsurvivalbetweenthetwostudiedperiods.
We report a low long-term survival rate among young stroke patients in Estonia. Increasing age and hemorrhagic stroke subtype
were associated with lower survival. We have previously shown a worse outcome for 1-year survival compared to other studies
and currently this trend continues for 5- and 7-year survival rates. In fact, these are the lowest survival rates for the combined and
separate stroke subtypes reported so far.
1.Introduction
A young patient with a stroke is always a challenge, even
for a stroke physician. Although the outcome of a stroke in
the young is believed to be better, it still has a signiﬁcant
impact on the person’s quality of life and moreover can be
fatal. Data about long-term survival of young stroke patients
are scarce and are usually collected retrospectively or are
hospital-based [1–20]. Most of these studies have included
ischemic strokes and have reported a rather good prognosis
but some of the studies were performed years ago when the
diagnostic criteria for stroke diﬀered considerably.
Stroke incidence is known to be higher in developing
countries, and also in Eastern Europe, compared to the
Western countries. In Estonia, the total ﬁrst-ever stroke
incidence is comparable to that of other European countries,
but is higher for the younger age groups [21]. The incidence
declined by 2001–2003, but it was still 13 per 100 000 for the
subjects aged 0 to 44 and 118 per 100 000 for subjects aged
45 to 54 years in Tartu, Estonia [22]. In addition, the 1-year
outcome of stroke in terms of functional deﬁcit and survival
has also been worse compared to the data from several other
study centres [23].
The aim of this paper was to evaluate long-term survival
of young stroke patients in Estonia, analyse changes in
survival between 1991 to 2003, and compare the results with
other studies.
2. Methods
Datafromthetwopopulation-basedstrokeregistries[21,25]
from Tartu, Estonia, were used. The ﬁrst registry included all
ﬁrst-ever in a lifetime strokes from 1991 to 1993 (3 years)
and the other registry included patients from 2001 to 2003
(2 years). These registries included both hospitalised and
nonhospitalised cases and prospective “hot pursuit” case-
ﬁnding methods were used to assure the inclusion of all
stroke patients in the area. The more detailed description2 Stroke Research and Treatment
Table 1: Median survival rates by age group, stroke subtype, and gender.
Time Survival 95% CI Survival 95% CI Survival 95% CI P value
All Men Women
1 year 0.70 0.62–0.78 0.73 0.63–0.83 0.65 0.53–0.80
0.45 5 years 0.63 0.55–0.72 0.61 0.52–0.73 0.65 0.53–0.80
7 years 0.61 0.53–0.70 0.59 0.49–0.71 0.65 0.53–0.80
0–44 years (n = 41) 45–54 years (n = 88)
1 year 0.85 0.75–0.97 0.63 0.53–0.74
0.03 5 years 0.73 0.61–0.89 0.58 0.49–0.69
7 years 0.73 0.61–0.89 0.56 0.46–0.67
BI (n = 91) ICH (n = 26) UND (n = 12)
1 year 0.79 0.71–0.88 0.39 0.24–0.63 0.67 0.45–0.99
<0.001 5 years 0.71 0.63–0.81 0.31 0.17–0.55 0.67 0.45–0.99
7 years 0.69 0.60–0.79 0.31 0.17–0.55 0.67 0.45–0.99
BI 0–44 years (n = 30) BI 45–54 years (n = 61)
1 year 0.90 0.80–1.00 0.74 0.64–0.86
0.15 5 years 0.77 0.63–0.93 0.69 0.58–0.82
7 years 0.77 0.63–0.93 0.66 0.55–0.79
of methods used for data collection, deﬁnitions, and other
criteria for these registries have been published earlier [21,
22, 25].
In this current study, patients aged <55 years at stroke
onset were included in the analysis. The Estonian Population
Register was used for obtaining survival data. The cut-oﬀ
point for survival data was February 2001 for the ﬁrst and
January 2011 for the second registry for the evaluation of the
7-year outcome.
The study was approved by the Ethics Review Committee
on Human Research of the University of Tartu.
2.1. Statistical Methods. Survival rate was estimated by the
Kaplan-Meier method (1-, 5-, and 7-year survival rate).
Survival distributions were compared using the log-rank
test. P values less than 0.05 were considered signiﬁcant. The
analysis was carried out by the statistical software package R.
3. Results
A total of 1280 patients, (501 men and 779 women) with
ﬁrst-ever stroke, were registered during the 5-year study
period, with 829 patients from 1991 to 1993 and 451 patients
from 2001 to 2003. Patients with subarachnoid haemorrhage
(64 patients) were excluded from this current analysis and
additionally 10 patients were lost for the long-term followup.
From the group of 1206 patients, 129 (11%) were <55
years of age (38% women and 62% men), and these were
included in the survival analysis. The mean age of patients
was 46.1 (±9.6) years (range 1 to 55 years). Of them, 91
(71%) had a brain infarction (BI), 26 (20%) an intracerebral
haemorrhage (ICH), and 12 (9%) had an undeﬁned type of
stroke (UND). Only 3 patients were <15 years of age (2 of
them with BI and one with ICH). Perinatal strokes were not
included.
Sixty-four of 129 patients (50%) had hypertension,
4 (3%) atrial ﬁbrillation, 17 (13%) diabetes mellitus, 20
(16%) ischemic heart disease, and 7 (5%) had had a
previous transient ischemic attack. In 48 patients (38%), no
cardiovascular risk factors were identiﬁed at stroke onset.
The survival rates by age, gender, and stroke subtypes are
shown in Table 1. For comparison with previous studies we
also calculated the survival rates for patients with ischemic
stroke aged 15 to 44 years. The 1-, 5-, and 7-year survival
rateswere0.89(95%CI0.79–1.00),0.75(95%CI0.61–0.93),
and 0.75 (0.61–0.93), respectively.
As expected, the survival rate was worse for patients with
ICH and for the older age group. There was no signiﬁcant
diﬀerence in overall survival rates between the two studied
periods (P = 0.8) nor in young ischemic stroke survival
between the two study periods (P = 0.6).
4. Discussion
The main ﬁnding of our study is the low long-term survival
rate among young ﬁrst-ever stroke patients. At the same time
most previous reports agree that although the survival of
youngstrokepatientsislowerthaninthegeneralpopulation,
itisstillcomparativelyhigh[17,26].Ourpreviousstudy[23]
has shown a worse outcome for 1-year survival compared to
other studies and currently this trend continues for 5- and
7-year survival rates. In fact, these are the lowest survival
rates for combined and separate stroke subtypes reported
so far. In our study increasing age (0–44 years versus 45–54
years) and hemorrhagic stroke subtype were associated with
lower long-term survival. Earlier studies have also found an
association between the male gender and higher mortality
in young stroke patients [2, 4]. Although this trend can also
be seen in our study, it did not reach statistical signiﬁcance.
T h em o r er e c e n ts t u d yb yP u t a a l ae ta l .[ 16] could also notStroke Research and Treatment 3
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Figure 1: Survival of young patients with ischaemic stroke in
diﬀerent studies [1, 2, 4, 16, 18, 24].
identify this association. Quite surprisingly, the survival rate
for women remained unchanged after 1 year.
The survival rates for young ischaemic stroke patients
from several studies are summarized in Figure 1. The general
annual survival rate follows the pattern of earlier studies
being clearly lowest in the ﬁrst year and signiﬁcantly
increases thereafter, but is constantly lower than other
studies. The diﬀerences in survival rates across the studies
could be associated with several aspects. The study type,
inclusion criteria, follow-up period, and type of data analysis
diﬀer across studies. All, with the exception of three [2, 17,
18], have been hospital based and do not represent a deﬁned
population. Although the follow-up periods in these studies
are variable, the trend of outcome is still obvious. The results
of our study come from two prospective population-based
registries. However, a limitation of our study is the small
sample size.
The main factor for low survival may be severe stroke,
and although there are no comparative data, we speculate
that stroke cases are more severe in Estonia. This may be
related to a higher prevalence of risk factors leading to a
w o r s eo u t c o m e .H o w e v e r ,i n3 8 %o fc a s e sn oc a r d i o v a s c u l a r
risk factors were identiﬁed despite extensive diagnostic tests.
This points to the fact that there may be also other possible
causes for higher stroke incidence and lower survival among
young subjects in Estonia, for example, genetics, lifestyle,
or environmental factors. However, these hypotheses are
diﬃcult to prove. And ﬁnally, the life expectancy in Estonia
was 75.8 years in 2010, 70.6 years for men and 80.8
years for women. Although this rate has constantly grown
during the past decade, it is still 3 to 4 years less for
women and 5 to 7 years less for men, compared to that
of most other European countries [27]. Still, there was no
signiﬁcant diﬀerence in stroke survival between the two
study periods.
Unfortunately, we were not able to identify the causes
of death of young stroke patients because of the strict
Estonian data protection legislation. The causes of death
are conﬁdential and coded linking between registries is not
allowed. As the cardiovascular mortality and deaths, due to
accidents and excess alcohol intake, are high in the young
Estonian population (especially in men), a number of our
young stroke patients might die due to other causes rather
than from stroke.
5. Conclusion
Long-term survival rates of young stroke patients diﬀer
signiﬁcantly across the world. The causes of high stroke
incidence and low survival rates in Eastern Europe can
be explained in some terms, but the proportion of stroke
patients with no identiﬁable risk factors is high. Future
studies and everyday clinical practice should focus on
thorough detection of the etiology of stroke, promoting a
healthy lifestyle, optimizing primary and secondary preven-
tion strategies thus decreasing the incidence of stroke and
achieving a better outcome for young stroke patients.
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